𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The 11 -year pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991

✍ Scribed by Dr. David H. van Thiel; Brian Carr; Shunzaburo Iwatsuki; R. Richard Selby; John J. Fung; Thomas E. Starzl

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
397 KB
Volume
53
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

Experience with liver transplantation over a period of 11 years at the University of Pittsburgh is presented. The application of liver transplantation to cases of hepatocellular carcinoma has changed considerably over this 1 1-year period with the sequential introduction of adjuvant and, more recently, neoadjuvant chemotherapy.

Results with the combination of chemotherapy plus surgery appear to be better than results with either agent alone. Moreover, the early results with neoadjuvant therapy appear to be better than those achieved with adjuvant therapy.

As a result of this experience, conceptual changes in the approach to the problem of hepatic cancer and the role of both chemotherapy and liver transplantation in its management have changed at the University of Pittsburgh. These changes are identified and discussed.

πŸ“œ SIMILAR VOLUMES

Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma: Lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy
✍ Francis Y. Yao; Nathan M. Bass; Nancy L. Ascher; John P. Roberts πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

We examined the impact of the Model for End-Stage Liver Disease (MELD) organ allocation scheme on 44 patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver transplantation (OLT) between February 2002 and January 2003, and compared the outcome with 58 patients listed in the 4 years be

Tools for monitoring patients with hepat
Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation
✍ Norman Kneteman; Tito Livraghi; David Madoff; Eduardo de SantibaΓ±ez; Michael Kew πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 192 KB

For patients who are initially being listed for liver transplantation and for patients who are seeking to retain their active status on the wait list, the first step in the diagnostic consideration of hepatocellular carcinoma (HCC) is the accurate identification and staging of the tumors. Advances i

Outcome of patients with hepatocellular
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system
✍ Michael Adler; Filip De Pauw; Pierre Vereerstraeten; Agnese Fancello; Jan Lerut; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 1 views

Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation, the rules governing priority and access to the waiting list are not well defined. Patient-and tumor-related variables were evaluated in 226 patients listed primarily for HCC in Belgium, a region whe

Expanded criteria for liver transplantat
Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the International Registry of Hepatic Tumors in Liver Transplantation
✍ Nicholas Onaca; Gary L. Davis; Robert M. Goldstein; Linda W. Jennings; GΓΆran B. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 344 KB πŸ‘ 2 views

Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Currently, deceased donor LT is approved by the United Network for Organ Sharing for patients with HCC who meet the Milan criteria of a single tumor up to 5 cm or up to 3 tumors up to 3 cm as determined by imaging